Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G

Mfold web server for nucleic acid folding and hybridization prediction

Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404

Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry

Basbaum, A. I., & Fields, H. L. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.07.030184.001521 · Cited by 2,687

Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics

Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214

Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction

Bond, C. E., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J. H., Strong, J. A., Leal, S. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9608 · Cited by 1,072

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

Duan, J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg055 · Cited by 931

Evolutionary changes in cis and trans gene regulation

Wittkopp, P. J., Haerum, B. K., & Clark, A. G. (2004) · Nature · doi:10.1038/nature02698 · Cited by 873

Endogenous opioid systems and alcohol addiction

Herz, A. (1997) · Psychopharmacology · doi:10.1007/s002130050169 · Cited by 755

A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients

Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571

Allelic Variation in Gene Expression Is Common in the Human GenomePreprint

Lo, H. S., Wang, Z., Hu, Y., Yang, H. H., Gere, S., Buetow, K. H., & Lee, M. P. (2003) · Genome Research · doi:10.1101/gr.1006603 · Cited by 446

A Haplotype Implicated in Schizophrenia Susceptibility Is Associated with Reduced COMT Expression in Human Brain

Bray, N. J., Buckland, P. R., Williams, N. M., Williams, H. J., Norton, N., Owen, M. J., & O’Donovan, M. C. (2003) · The American Journal of Human Genetics · doi:10.1086/376578 · Cited by 335

Sequence variability and candidate gene analysis in complex disease: association of micro opioid receptor gene variation with substance dependence

Hoehe, M. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.19.2895 · Cited by 288

Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study

Peckys, D. B., & Landwehrmeyer, G. B. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00251-6 · Cited by 273

15,000 Unique Zebrafish EST Clusters and Their Future Use in Microarray for Profiling Gene Expression Patterns During EmbryogenesisPreprint

Lo, J., Lee, S.-C., Xu, M., Liu, F., Ruan, H., Eun, A., He, Y., Ma, W., Wang, W., Wen, Z., et al. (2003) · Genome Research · doi:10.1101/gr.885403 · Cited by 265

Effect of the A118G polymorphism on binding affinity, potency and agonist‐mediated endocytosis, desensitization, and resensitization of the human mu‐opioid receptor

Beyer, A., Koch, T., Schröder, H., Schulz, S., & Höllt, V. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02340.x · Cited by 258

The Mu-Opioid Receptor Gene Polymorphism (A118G) Alters HPA Axis Activation Induced by Opioid Receptor Blockade

Wand, G. S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00294-9 · Cited by 247

A Single Nucleotide Polymorphic Mutation in the Human μ-Opioid Receptor Severely Impairs Receptor Signaling

Befort, K., Filliol, D., Décaillot, F. M., Gavériaux‐Ruff, C., Hoehe, M. R., & Kieffer, B. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006352200 · Cited by 241

Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden

Bart, G. B., Heilig, M. A., LaForge, K. S., Pollak, L., Leal, S. M., Ott, J., & Kreek, M. J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001504 · Cited by 179

Using reliability information to annotate RNA secondary structures

Zuker, M., & Jacobson, A. B. (1998) · RNA · doi:10.1017/s1355838298980116 · Cited by 174

Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations

Tan, E., Tan, C.-H., Karupathivan, U., & Yap, E. P. H. (2003) · Neuroreport · doi:10.1097/00001756-200303240-00008 · Cited by 173

Opioid Receptor Homo- and Heterodimerization in Living Cells by Quantitative Bioluminescence Resonance Energy Transfer

Wang, D., Sun, X., Bohn, L., & Sadée, W. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010272 · Cited by 160

Opioid receptor and peptide gene polymorphisms: potential implications for addictions

LaForge, K. S., Yuferov, V. P., & Kreek, M. J. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00819-0 · Cited by 152

Killing the messenger: new insights into nonsense-mediated mRNA decay

Byers, P. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14841 · Cited by 152

Genes Associated With Addiction: Alcoholism, Opiate, and Cocaine Addiction

Kreek, M. J., Nielsen, D. A., & LaForge, K. S. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:1:085 · Cited by 149

Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts

Szeto, C. Y.-K., Tang, N. L. S., Lee, D. T. S., & Stadlin, A. (2001) · Neuroreport · doi:10.1097/00001756-200105080-00011 · Cited by 145

Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the μ‐opioid receptor locus (OPRM1)

Hernández–Ávila, C. A., Wand, G. S., Luο, X., Gelernter, J. E., & Kranzler, H. R. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10054 · Cited by 144

Killing the messenger: new insights into nonsense-mediated mRNA decay

Byers, P. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214841 · Cited by 142

A genetic association study of the mu opioid receptor and severe opioid dependence

Crowley, J. J., Oslin, D. W., Patkar, A. A., Gottheil, E., DeMaria, P. A., Brien, C. P. O., Berrettini, W. H., & Grice, D. E. (2003) · Psychiatric Genetics · doi:10.1097/00041444-200309000-00006 · Cited by 136

SNP genotyping on pooled DNAs: comparison of genotyping technologies and a semi automated method for data storage and analysis

Hellard, S. L. (2002) · Nucleic Acids Research · doi:10.1093/nar/gnf070 · Cited by 129

Opiates, opioids and addiction.

Kreek, M. J. (1996) · PubMed · Cited by 126

Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European‐Americans

Luο, X., Kranzler, H. R., Zhao, H., & Gelernter, J. E. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20034 · Cited by 108

The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain

Bray, N. J., Buckland, P. R., Hall, H., Owen, M. J., & O’Donovan, M. C. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001366 · Cited by 108

Polymorphisms affecting gene regulation and mRNA processing: Broad implications for pharmacogenetics

JOHNSON, A., WANG, D., & SADEE, W. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.001 · Cited by 97

A functional polymorphism within the μ-opioid receptor gene and risk for abuse of alcohol and other substances

Schinka, J. A., Town, T., Abdullah, L. I., Crawford, F., Ordorica, P. I., Francis, E. M., Hughes, P. H., Graves, A. B., Mortimer, J. A., & MULLAN, M. J. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000951 · Cited by 97

Cocaine, Dopamine and the Endogenous Opioid System

Kreek, M. J. (1996) · Journal of Addictive Diseases · doi:10.1300/j069v15n04_05 · Cited by 95

The genomics of gene expression

Stamatoyannopoulos, J. A. (2004) · Genomics · doi:10.1016/j.ygeno.2004.05.002 · Cited by 95

Opioid receptors: Some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases

Kreek, M. J. (1996) · Neurochemical Research · doi:10.1007/bf02532387 · Cited by 87

Genetic Variants of the Human H+/Dipeptide Transporter PEPT2: Analysis of Haplotype Functions

Pinsonneault, J. K., Nielsen, C. U., & Sadée, W. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073098 · Cited by 85

Allelic variations in gene expression

Yan, H., & Zhou, W. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200401000-00008 · Cited by 57

Allelic expression imbalance of the human CYP3A4 gene and individual phenotypic status

Hirota, T., Ieiri, I., Takane, H., Maegawa, S., Hosokawa, M., Kobayashi, K., Chiba, K., Nanba, E., Oshimura, M., Satō, T., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh313 · Cited by 51

Post‐transcriptional control of gene expression: effectors of mRNA decay

Arraiano, C. M., & Maquat, L. E. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03545.x · Cited by 38

Five exon 1 variants of mu opioid receptor and vulnerability to alcohol dependence.

Gscheidel, N., Sander, T., Wendel, B., Heere, P., Lg, S., Rommelspacher, H., Hoehe, M. R., & Samochowiec, J. (2000) · PubMed · Cited by 34

Tissue Distribution and Pharmacological Potential of SM-16896, a Novel Oestrogen-bisphosphonate Hybrid Compound

Tsushima, N., Yabuki, M., Harada, H., Katsumata, T., Kanamaru, H., Nakatsuka, I., Yamamoto, M., & Nakatsuka, M. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001773652 · Cited by 26

Translational control of the rat angiotensin type 1a receptor by alternative splicing

Zhang, Y., Ji, H., Fabucci, M. E., Falconetti, C., Zheng, W. H., & Sandberg, K. L. (2004) · Gene · doi:10.1016/j.gene.2004.07.017 · Cited by 22

International Narcotic Research Conference

(1978) · Brain Research Bulletin · doi:10.1016/0361-9230(78)90048-5 · Cited by 6

Molecular mechanisms of opioid receptor-dependent signaling and behavior

Al-Hasani, R., & Bruchas, M. R. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318238bba6 · Cited by 1,067

Mu Opioids and Their Receptors: Evolution of a Concept

Pasternak, G. W., & Pan, Y. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007138 · Cited by 582

An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence: Results From the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study

Anton, R. F., Oroszi, G., O’Malley, S., Couper, D., Swift, R., Pettinati, H., & Goldman, D. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.2.135 · Cited by 451

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 , OPRM1 , and COMT Genotypes and Select Opioid Therapy

Crews, K. R., Monte, A. A., Huddart, R., Caudle, K. E., Kharasch, E. D., Gaedigk, A., Dunnenberger, H. M., Leeder, J. S., Callaghan, J. T., Samer, C. F., et al. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2149 · Cited by 448

Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory

Zhang, Y., Bertolino, A., Fazio, L., Blasi, G., Rampino, A., Romano, R., Lee, M. T., Xiao, T., Papp, A. C., Wang, D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707106104 · Cited by 436

Gene Variant Suggests Link To Addiction Vulnerability

Milne, D. (2005) · Psychiatric News · doi:10.1176/pn.40.21.0028

Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?

Mura, E., Govoni, S. M., Racchi, M., Carossa, V., Ranzani, G. N., Allegri, M., & van Schaik, R. H. N. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 7

Single‐nucleotide polymorphism (A118G) in exon 1 ofOPRM1gene causes alteration in downstream signaling by mu‐opioid receptor and may contribute to the genetic risk for addiction

Deb, I., Chakraborty, J., Gangopadhyay, P. K., Choudhury, S. R., & Das, S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06472.x · Cited by 105

OPRM1 SNP (A118G): Involvement in disease development, treatment response, and animal models

Mague, S. D., & Blendy, J. A. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.12.016 · Cited by 138

Synaptic Regulation by OPRM1 Variants in Reward Neurocircuitry

Popova, D., Desai, N., Blendy, J. A., & Pang, Z. P. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2317-18.2019 · Cited by 22